Login to Your Account

Pharma: Other News To Note

Friday, August 10, 2012
• Vanda Pharmaceuticals Inc., of Washington, said the Israeli Ministry of Health granted market approval for Fanapt (iloperidone) for the treatment of schizophrenia. Vanda will commercialize the drug in Israel through its partner Megapharm Ltd., of Raanana, Israel.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription